Skip to content

Vivani Medical VANI Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Amgen logo
AmgenAMGN
Prime Medicine logo
Prime MedicinePRME
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's accrued liabilities, current?
Vivani Medical (VANI) reported accrued liabilities, current of $1.5M in Q1 2026.
How has Vivani Medical's accrued liabilities, current changed year-over-year?
Vivani Medical's accrued liabilities, current decreased by 19.1% year-over-year, from $1.86M to $1.5M.
What is the long-term trend for Vivani Medical's accrued liabilities, current?
Over 5 years (2020 to 2025), Vivani Medical's accrued liabilities, current has grown at a 7.5% compound annual growth rate (CAGR), from $1.21M to $1.74M.